Enhanced Expression of Unique Gangliosides with GM2-determinant in Human Uterine Cervical Carcinoma-derived Cell Lines
Overview
Endocrinology
Affiliations
Monoclonal antibody YHD-06 generated by immunization with GM2 reacted with gangliosides with GM2-determinant, i.e., GM2, GalNAc-GM1b and GalNAc-GD1a, among which GalNAc-GD1a was characterized as an antigen of autoimmune peripheral neuropathies including Guillain-Barré syndrome. When glycolipids were examined by TLC-immunostaining with YHD-06 in seven human cervical carcinoma-derived cell lines, GM2 was found in all cell lines, amounting to 15.5 % to 57.5 % of total gangliosides. Whereas GalNAc-GD1a was present in three cell lines, amounting to 5.4-17.5 % of total gangliosides, and GalNAc-GM1b in four cell lines in amounts of less than 2 %. The elevated amounts of gangliosides with GM2 determinant were closely correlated with the relative intensities of gene expression of GalNAc transferase, this being characteristic of cervical carcinoma-derived cells. However, in tissues from patients with several histological types of cervical carcinomas, GM3 was ubiquitously expressed in amounts of more than 66 % of total gangliosides, GM2 was expressed in only five of 15 tissues, and both GalNAc-GM1b and GalNAc-GD1a were not even detected in trace amounts. Since GM1 was detected in all tissues in amounts of less than 0.06 μg/mg dried tissue, all cervical carcinoma tissues were revealed to exhibit GM2 synthesis, indicating that enhanced synthesis of gangliosides with GM2 determinant is a characteristic of cultivated cells in vitro. Similarly, although I(3)SO3-GalCer was not present in the squamous cell carcinoma (SCC) tissues, SCC-derived cells selectively expressed II(3)SO3-LacCer. Since enhanced synthesis of GM2 has been reported in SV-40 virus-transfected fibroblasts, papilloma virus might be involved in the expression of GM2 in cervical carcinoma-derived cells.
Tanaka K, Murakami I, Mikami M, Aoki D, Iwamori M Hum Cell. 2023; 36(3):1199-1203.
PMID: 36932279 PMC: 10110664. DOI: 10.1007/s13577-023-00864-z.
Pervan M, Marijan S, Markotic A, Pilkington L, Haverkate N, Barker D Int J Mol Sci. 2022; 23(19).
PMID: 36232754 PMC: 9569594. DOI: 10.3390/ijms231911457.
Tanaka K, Suzuki A, Aoki D, Iwamori M Glycoconj J. 2019; 36(3):219-226.
PMID: 31098851 DOI: 10.1007/s10719-019-09873-3.